123 related articles for article (PubMed ID: 37809728)
1. A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance.
Jeelani S; Kouznetsova N
Heliyon; 2023 Sep; 9(9):e19993. PubMed ID: 37809728
[TBL] [Abstract][Full Text] [Related]
2. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
Vojta J; Jedlička A; Coufal P; Janečková L
J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets.
Jeelani S; Soukhova N
J Pharm Biomed Anal; 2021 Feb; 195():113858. PubMed ID: 33388642
[TBL] [Abstract][Full Text] [Related]
4. Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations.
Shah DA; Bhatt KK; Mehta RS; Baldania SL; Gandhi TR
Indian J Pharm Sci; 2008 Nov; 70(6):754-60. PubMed ID: 21369436
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
Marisetti VM; Katakam P; Siddhani VK; Katari NK
Biomed Chromatogr; 2021 Nov; 35(11):e5194. PubMed ID: 34110035
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of amlodipine and aliskren in tablets by high-performance liquid chromatography.
Özdemir FA; Akyüz A
J Chromatogr Sci; 2014 Aug; 52(7):685-90. PubMed ID: 23839804
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a simultaneous HPLC method for estimation of bisoprolol fumarate and amlodipine besylate from tablets.
Vora DN; Kadav AA
Indian J Pharm Sci; 2008; 70(4):542-6. PubMed ID: 20046793
[TBL] [Abstract][Full Text] [Related]
9. Method development and validation of HPLC tandem/mass spectrometry for quantification of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical formulations.
Duraisamy K; Jaganathan KS; Krishna MV
Res Pharm Sci; 2017 Aug; 12(4):307-314. PubMed ID: 28855942
[TBL] [Abstract][Full Text] [Related]
10. A validated stability-indicating liquid chromatographic method for determination of degradation impurities and diastereomers in voriconazole tablets.
Shaikh KA; Patil AT
Sci Pharm; 2012; 80(4):879-88. PubMed ID: 23264937
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Estimation of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a High Performance Liquid Chromatographic (RP-HPLC) Method.
Patel DB; Mehta FA; Bhatt KK
Sci Pharm; 2012; 80(3):581-90. PubMed ID: 23008807
[TBL] [Abstract][Full Text] [Related]
12. Development of Novel RP-HPLC Method for Separation and Estimation of Critical Geometric Isomer and Other Related Impurities of Tafluprost Drug Substance and Identification of Major Degradation Compounds by Using LC-MS.
Sreenivasulu J; Venkata Ramana P; Sampath Kumar Reddy G; Rakesh M; Nagaraju ChV; Thirumalai Rajan S; Eswaraiah S; Kishore M; Ramakrishna M
J Chromatogr Sci; 2016 Sep; 54(8):1397-407. PubMed ID: 27226462
[TBL] [Abstract][Full Text] [Related]
13. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of an HPLC Method Using an Experimental Design for Analysis of Amlodipine Besylate and Enalapril Maleate in a Fixed-dose Combination.
Sarısaltık Yaşın D; Arslantürk Bingül A; Karaküçük A; Teksin ZŞ
Turk J Pharm Sci; 2021 Jun; 18(3):306-318. PubMed ID: 34157820
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous estimation of amlodipine besylate and nebivolol hydrochloride in tablet dosage forms by reverse phase-high-performance liquid chromatographic using ultraviolet detection.
Sharma D; Jain A; Shrivastava A
Pharm Methods; 2011 Jan; 2(1):9-14. PubMed ID: 23781423
[TBL] [Abstract][Full Text] [Related]
16. Stability-indicating HPLC method for the determination of darunavir ethanolate.
Reddy BV; Jyothi G; Reddy BS; Raman NV; Reddy KS; Rambabu C
J Chromatogr Sci; 2013; 51(5):471-6. PubMed ID: 23097581
[TBL] [Abstract][Full Text] [Related]
17. Rapid simultaneous determination of telmisartan, amlodipine besylate and hydrochlorothiazide in a combined poly pill dosage form by stability-indicating ultra performance liquid chromatography.
Nalwade S; Ranga Reddy V; Durga Rao D; Koteswara Rao I
Sci Pharm; 2011; 79(1):69-84. PubMed ID: 21617773
[TBL] [Abstract][Full Text] [Related]
18. A validated stability-indicating LC method for the separation of enantiomer and potential impurities of Linezolid using polar organic mode.
Satyanarayana Raju T; Vishweshwari Kutty O; Ganesh V; Yadagiri Swamy P
J Pharm Anal; 2012 Aug; 2(4):272-278. PubMed ID: 29403753
[TBL] [Abstract][Full Text] [Related]
19. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2021 Sep; 59(9):830-846. PubMed ID: 33420506
[TBL] [Abstract][Full Text] [Related]
20. Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product.
Naidu KR; Kale UN; Shingare MS
J Pharm Biomed Anal; 2005 Sep; 39(1-2):147-55. PubMed ID: 15939562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
